More molecules for tuberculosis
Scientists are collaborating on a new international research project to identify antibiotics that can kill tuberculosis and fight resistant strains.
Mar 11, 2011
not rated yet
0
Mar 11, 2011
not rated yet
0
EU steps up generic pharma anti-trust probe
Europe stepped up action against drug companies snarling up the entry of cheaper generic medicines onto markets, announcing Friday spot inspections confirmed by British No.2 AstraZeneca.
Dec 03, 2010
not rated yet
0
AstraZeneca cancer drug carries toxic risks: FDA
An experimental drug developed by AstraZeneca to treat a rare form of thyroid cancer carries "substantial toxicity" risks, the US Food and Drug Administration warned Tuesday.
Nov 30, 2010
not rated yet
0
A better way to target tumors
In the past 40 years, scientists have learned a great deal about how cells become cancerous. Some of that knowledge has translated to new treatments, but most of the time doctors are forced to rely on standard ch ...
Nov 15, 2010
5 / 5 (1)
0
Cholesterol drugs for the healthy still debatable
(AP) -- Should healthy people with low cholesterol take a pill to lower their cholesterol even more in hopes of preventing heart problems? The question is dividing heart doctors and confusing patients.
Jun 28, 2010
5 / 5 (2)
0
Drug companies share data to speed brain research
(AP) -- In an unusual step, a dozen competing drug companies have agreed to share data on thousands of Alzheimer's patients in hopes that the extra information will spark new ideas for treatments.
Jun 11, 2010
5 / 5 (2)
0
A new method for developing safer drugs
Amodiaquine was introduced as an antimalarial drug, but was withdrawn when serious adverse effects were observed. Scientists at the University of Gothenburg, Sweden, have now developed a method that can be used to develop ...
May 10, 2010
not rated yet
0
Takeda renames heartburn drug to avoid errors
(AP) -- Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.
Mar 04, 2010
not rated yet
0
FDA confirms benefits of Crestor in more patients
(AP) -- Federal scientists say AstraZeneca's cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain.
Dec 11, 2009
4 / 5 (1)
0
Newer Anti-Clotting Medication Found to Be More Effective
(PhysOrg.com) -- A large head-to-head study of two anti-clotting medications for heart patients has found that the investigational compound ticagrelor (Brilinta) was more effective at reducing cardiovascular death than the ...
Aug 30, 2009
4 / 5 (2)
0
Study shows experimental drug cuts stroke risk
(AP) -- An experimental drug reduces the stroke risk in patients with irregular heartbeats by more than three times, compared with the popular drug warfarin - but possibly at a cost, according to new research released Sunday.
Aug 30, 2009
5 / 5 (1)
0
Project Zero Delay accelerates drug's path to clinical trial
A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six ...
Aug 03, 2009
not rated yet
0
FDA weighs approval of psychiatric drugs for kids
(AP) -- Three blockbuster psychiatric drugs currently approved for adults also appear to work in adolescents, though federal health officials have concerns about exposing younger patients to the drugs' side effects.
Jun 05, 2009
3 / 5 (2)
3
Abbott, AstraZeneca seek cholesterol pill approval
(AP) -- Abbott Laboratories and AstraZeneca PLC on Thursday asked the Food and Drug Administration to approve a drug that combines their cholesterol pills TriLipix and Crestor.
Jun 04, 2009
4 / 5 (1)
0
AstraZeneca, Merck collaborate on cancer treatment
(AP) -- AstraZeneca PLC and Merck & Co. said Monday they will jointly develop a pair of drugs meant to hit cancer with a one-two punch, part of a growing trend of combination cancer treatments.
Jun 01, 2009
not rated yet
0
